
Regulators say they’ll judge AI use against your own internal policies. Our panel breaks down what that means for implementation, inspections, and December’s playbook.

Regulators say they’ll judge AI use against your own internal policies. Our panel breaks down what that means for implementation, inspections, and December’s playbook.

Jaenisch, Muraru, and Pandey join PharmTech's Cole to discuss FDA's generative AI paper, ARPA-H's SURPASS trials, and AI accountability.

PharmTech AI Pulse Check episode 2 covers AI data governance, API-gated journals, watermarking limits, and why attribution beats detection in GxP.

PharmTech AI Pulse Check debuts: pharma experts tackle GxP 'slop,' multi-agent validation risk, OCR document mining, personalized mRNA cancer therapy.